111 related articles for article (PubMed ID: 25812649)
1. miR-218 suppresses cardiac myxoma proliferation by targeting myocyte enhancer factor 2D.
Cao Q; Dong P; Wang Y; Zhang J; Shi X; Wang Y
Oncol Rep; 2015 May; 33(5):2606-12. PubMed ID: 25812649
[TBL] [Abstract][Full Text] [Related]
2. PPARγ suppresses the proliferation of cardiac myxoma cells through downregulation of MEF2D in a miR-122-dependent manner.
Qiu Y; Yang J; Bian S; Chen G; Yu J
Biochem Biophys Res Commun; 2016 Jun; 474(3):560-565. PubMed ID: 27109478
[TBL] [Abstract][Full Text] [Related]
3. The involvement of myocyte enhancer factor 2D in regulating tumor biology of cardiac myxoma.
Huo Y; Zhao Q; Wang C; Zhao F; Du Y; Sun W
Tumour Biol; 2016 Apr; 37(4):5405-11. PubMed ID: 26563368
[TBL] [Abstract][Full Text] [Related]
4. MEF2D/Wnt/β-catenin pathway regulates the proliferation of gastric cancer cells and is regulated by microRNA-19.
Xu K; Zhao YC
Tumour Biol; 2016 Jul; 37(7):9059-69. PubMed ID: 26762410
[TBL] [Abstract][Full Text] [Related]
5. miR-217 suppresses proliferation and promotes apoptosis in cardiac myxoma by targeting Interleukin-6.
Zhang J; Wang C; Xu H
Biochem Biophys Res Commun; 2017 Aug; 490(3):713-718. PubMed ID: 28642131
[TBL] [Abstract][Full Text] [Related]
6. MEF2D overexpression contributes to the progression of osteosarcoma.
Yu H; Sun H; Bai Y; Han J; Liu G; Liu Y; Zhang N
Gene; 2015 Jun; 563(2):130-5. PubMed ID: 25814384
[TBL] [Abstract][Full Text] [Related]
7. miR-218 suppressed the growth of lung carcinoma by reducing MEF2D expression.
Song L; Li D; Zhao Y; Gu Y; Zhao D; Li X; Bai X; Sun Y; Zhang X; Sun H; Wang Y; Peng L
Tumour Biol; 2016 Mar; 37(3):2891-900. PubMed ID: 26409449
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genes.
Ma L; Liu J; Liu L; Duan G; Wang Q; Xu Y; Xia F; Shan J; Shen J; Yang Z; Bie P; Cui Y; Bian XW; Prieto J; Avila MA; Qian C
Cancer Res; 2014 Mar; 74(5):1452-62. PubMed ID: 24390737
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of miR-18a negatively regulates myocyte enhancer factor 2D to increase the permeability of the blood-tumor barrier via Krüppel-like factor 4-mediated downregulation of zonula occluden-1, claudin-5, and occludin.
Zhao YY; Zhao LN; Wang P; Miao YS; Liu YH; Wang ZH; Ma J; Li Z; Li ZQ; Xue YX
J Neurosci Res; 2015 Dec; 93(12):1891-902. PubMed ID: 26356851
[TBL] [Abstract][Full Text] [Related]
10. miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer.
Zhang Y; Wang X; Wang Z; Tang H; Fan H; Guo Q
Oncol Rep; 2015 May; 33(5):2592-8. PubMed ID: 25738520
[TBL] [Abstract][Full Text] [Related]
11. Myocyte enhancer factor 2D promotes tumorigenicity in malignant glioma cells.
Zhao Y; Li Y; Ma Y; Wang S; Cheng J; Yang T; Sun Z; Kuang Y; Huang H; Fan K; Gu J
Tumour Biol; 2016 Jan; 37(1):601-10. PubMed ID: 26234765
[TBL] [Abstract][Full Text] [Related]
12. miR-1244/Myocyte Enhancer Factor 2D Regulatory Loop Contributes to the Growth of Lung Carcinoma.
Zhang R; Zhang Y; Li H
DNA Cell Biol; 2015 Nov; 34(11):692-700. PubMed ID: 26355845
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-29c overexpression inhibits proliferation and promotes apoptosis and differentiation in P19 embryonal carcinoma cells.
Liu M; Chen Y; Song G; Chen B; Wang L; Li X; Kong X; Shen Y; Qian L
Gene; 2016 Jan; 576(1 Pt 2):304-11. PubMed ID: 26484393
[TBL] [Abstract][Full Text] [Related]
14. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
[TBL] [Abstract][Full Text] [Related]
15. miR-103 promotes 3T3-L1 cell adipogenesis through AKT/mTOR signal pathway with its target being MEF2D.
Li M; Liu Z; Zhang Z; Liu G; Sun S; Sun C
Biol Chem; 2015 Mar; 396(3):235-44. PubMed ID: 25400071
[TBL] [Abstract][Full Text] [Related]
16. MiR-335 promotes cell proliferation by inhibiting MEF2D and sensitizes cells to 5-Fu treatment in gallbladder carcinoma.
Wang W; Chen LC; Qian JY; Zhang Q
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9829-9839. PubMed ID: 31799650
[TBL] [Abstract][Full Text] [Related]
17. miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1.
Guo J; Xia B; Meng F; Lou G
Biochem Biophys Res Commun; 2013 Nov; 441(2):357-63. PubMed ID: 24144591
[TBL] [Abstract][Full Text] [Related]
18. [miR-216b suppresses cell proliferation and invasion by targeting PKCα in nasopharyngeal carcinoma cells].
Deng M; Liu JF; Gu YX; Zheng GP; He ZM
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):645-50. PubMed ID: 24332049
[TBL] [Abstract][Full Text] [Related]
19. The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression.
Zhao M; Huang J; Gui K; Xiong M; Cai G; Xu J; Wang K; Liu D; Zhang X; Yin W
Int J Mol Med; 2014 Dec; 34(6):1565-72. PubMed ID: 25318625
[TBL] [Abstract][Full Text] [Related]
20. Gene expression analysis to identify mRNA markers of cardiac myxoma.
Skamrov AV; Nechaenko MA; Goryunova LE; Feoktistova ES; Khaspekov GL; Kovalevsky DA; Vinnitsky LI; Sheremeteva GF; Beabealashvilli RSh
J Mol Cell Cardiol; 2004 Sep; 37(3):717-33. PubMed ID: 15350845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
